Urethritis in men: Difference between revisions
Line 30: Line 30:
*Metronidazole 2 gm PO x 1, '''OR'''
*Metronidazole 2 gm PO x 1, '''OR'''
*Tinidazole 2 gm PO x 1
*Tinidazole 2 gm PO x 1
===[[Antibiotics]]===
{{Urethritis antibiotics}}


==Disposition==
==Disposition==

Revision as of 10:42, 31 October 2017

Background

Genitourinary infection

(1) Human urinary system: (2) kidney; (3) renal pelvis; (4) ureter; (5) urinary bladder (6) urethra.
Additional structures: (7) adrenal gland; (8) renal artery and vein; (9) inferior vena cava; (10) abdominal aorta; (11) common iliac artery and vein; (12) liver; (13) large intestine; (14) pelvis.

"UTI" frequently refers specifically to acute cystitis, but may also be used as a general term for all urinary infections; use location-specific diagnosis.

Clinical Features

Differential Diagnosis

Dysuria

Evaluation

Management

Initial antimicrobial treatment is typically empiric, depending on risk for gonococcal versus nongonococcal urethritis

Gonococcal

Will also treat chlamydia

Nongonococcal

Chlamydia most likely pathogen

Recurrent or Persistent

Target M. genitalium, a common cause of persistent nongonococcal urethritis

  • Azithromycin 1 gm) PO x 1 (if not administered in the initial regimen), OR
  • Moxifloxacin 400 mg daily x 7 days (if the initial failed regimen included azithromycin)

Consider coverage of T. vaginalis, among men who have sex with women

  • Metronidazole 2 gm PO x 1, OR
  • Tinidazole 2 gm PO x 1

Disposition

  • Outpatient

See Also

References

Retrieved from "https://www.wikem.org/w/index.php?title=Urethritis_in_men&oldid=162144"